MedPath

Dexmedetomidine Infusion in Hypospadias Surgery

Phase 3
Completed
Conditions
Pain
Interventions
Registration Number
NCT00926705
Lead Sponsor
University of Jordan
Brief Summary

The investigators hypothesize that giving Dexmedetomidine in combination with Fentanyl for pediatric patients undergoing hypospadias surgery, will reduce the fentanyl requirement for intraoperative and postoperative analgesia.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
48
Inclusion Criteria
  • Children aged 1-12 years undergoing hypospadias repair
Exclusion Criteria
  • Allergy to Dexmedetomidine
  • Preoperative use of sedatives or analgesics
  • cardiac diseases
  • Children with mental retardation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Dexmedetomidine and FentanylDexmedetomidine and FentanylThis group received a combination of Dexmedetomidine (1 ug/kg) and Fentanyl (1.79 ug/kg). Total number of patients in this group 24.
FentanylFentanylThis group received Fentanyl at a dose of 2 ug/kg initially, followed by boluses to keep the patient hemodynamically stable.
Primary Outcome Measures
NameTimeMethod
Intraoperative and postoperative fentanyl requirement (in microg/kg)6/2008-1/2009
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Jordan University Hospital

🇯🇴

Amman, Jordan

© Copyright 2025. All Rights Reserved by MedPath